Progenity to Report Fourth Quarter and Full-Year 2021

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for...

Related Keywords

Kristin Schaeffer ,Chuck Padala ,Progenity Inc ,Nasdaq ,Investor Relations ,Nasdaq Prog ,Progenity ,Nc ,